Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
•Phase 2a To determine the Maximal Tolerated Dose (MTD) of lenalidomide in combination with cetuximab in subjects with KRAS mutant metastatic CRC. •Phase 2b To determine the response rate in subjects with KRAS mutant metastatic CRC.
Critère d'inclusion
- Colorectal Cancer